home | section | immunophenotyping
Routine antibody panels
| Panel | Identification of cell types |
|---|---|
| Acute leukaemia panel | T cells: CD1a(cy), CD2, CD3 (surface and cytoplasmic), CD4, CD5, CD7, CD8 and CD99 B cells: CD9, CD19, CD20, CD22 and CD79a(cy) myeloid: CD11b, CD13, CD14, CD15, CD16, CD33, CD64, CD117 and MPO(cy) blasts: CD34 and TdT others: CD10, CD36, CD45, CD56, CD61, CD123, CD303, CD304 and HLA-DR |
| Lymphocyte panel | T cells: CD2, CD3, CD4, CD5, CD7, CD8, CD30, and PD1 B cells: CD19, CD20, CD22, CD23, CD79b, and κ/λ light chains NK cell: CD16, CD56 and CD57 others: CD10, CD11c, CD25, CD27, CD38, CD43, CD45, CD75s, CD81, CD103, CD123, and CD200 |
| Plasma cell panel | cytoplasmic κ/λ, CD19, CD20, CD38, CD45, CD56 and CD138 others: CD27 and CD117 |
| Stem cell enumeration | CD34 and CD45 |
| PNH | CD15, CD24 and CD66b (neutrophils) glycophorin A, CD59 (red cells) (GPI-linked antigens) |
| Hereditary spherocytosis screening | eosin-5-maleimide |
| Immunological platelet enumeration | CD61/CD41 ICSH reference method |